PHYH and nonpapillary renal cell carcinoma: This occurs alters alpha-oxidation pathway which may potentially be a targeted pathway for future studies, Moreover, PPAR signalling, pyruvate metabolism, butanoate metabolism, and RAS may be the key pathway regulated by PHYH in ccRCC.